7.79

1.39% -0.11

After Hours: 7.79

Cumberland Pharmaceuticals Inc (CPIX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cumberland Pharmaceuticals Inc stock is traded at $7.79, with a volume of 57,819. It is down -1.39% in the last 24 hours and up +11.52% over the past month. Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Previous Close:

$7.90

Open:

$7.85

24h Volume:

57,819

Relative Volume:

0.54

Market Cap:

$116.72M

Revenue:

$41.94M

Net Income/Loss:

$-7.40M

P/E Ratio:

-15.79

EPS:

-0.4935

Net Cash Flow:

$1.29M

1W Performance:

-0.13%

1M Performance:

+11.52%

6M Performance:

+100.77%

1Y Performance:

+160.54%

1-Day Range:

$7.74

$8.07

1-Week Range:

$7.4767

$8.45

52-Week Range:

$1.85

$8.45

Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile

Name

Cumberland Pharmaceuticals Inc

Sector

Healthcare (1080)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

615-255-0068

Address

1600 WEST END AVENUE, NASHVILLE,, TN

Employee

Twitter

Next Earnings Date

2026-08-04

Latest SEC Filings

CPIX's Discussions on Twitter

Compare CPIX vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CPIX Cumberland Pharmaceuticals Inc	7.79	118.52M	41.94M	-7.40M	1.29M	-0.4935
TAK Takeda Pharmaceutical Co Adr	17.63	55.60B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.77	42.81B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.70	43.16B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.79	30.39B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	499.73	21.95B	3.17B	1.29B	1.01B	27.09

Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-12-12	Reiterated	UBS	Neutral
Feb-01-11	Reiterated	UBS	Neutral
Dec-16-10	Downgrade	UBS	Buy → Neutral
Aug-17-10	Downgrade	Jefferies	Buy → Hold
Aug-17-10	Reiterated	Morgan Joseph	Buy
Aug-17-10	Reiterated	UBS	Buy
May-14-10	Reiterated	Morgan Joseph	Buy

View All

Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News

Aug 16, 2026

Price to book forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView

Aug 16, 2026

Aug 13, 2026

Cumberland Pharmaceuticals: Pivot Into Drug Development Creates Risk, Opportunity (CPIX) - Seeking Alpha

Aug 13, 2026

Aug 12, 2026

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - marketbeat.com

Aug 12, 2026

Aug 07, 2026

Cumberland Pharmaceuticals (CPIX) Slips 1.04% as Shares Test Key Support Near $7.22Volume Profile - dars.gov.et

Aug 07, 2026

Aug 06, 2026

Cumberland Pharmaceuticals (CPIX) Stock Cools As Cash Rich Biotech Pivot Begins - Sahm

Aug 06, 2026

Aug 05, 2026